TEVA
Teva- Pharmaceutical Industries Ltd.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Market Cap: 15.2 Billion
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Website: http://www.tevapharm.com
Shares Outstanding: 1.12 Billion
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.5550924587005794
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1734 trading days
From: 2015-07-27 To: 2024-03-07
Lowest Point:
Oklahoma judge blocks Teva's $85M settle in Oklahoma; shares down 6%
via: SeekingAlpha at 2019-06-12 07:11:11:000
Teva Pharmaceutical Industries ( TEVA -5.5% ) continues to battle bad news. Bloomberg reports that a district court judge in Oklahoma will not approve the company's $85M settlement over its role in the opioid epidemic there because AG Mike Hunter has not shown that the proceeds will go int… read more...
Oklahoma judge blocks Teva's $85M settle in Oklahoma; shares down 6%
via: SeekingAlpha at 2019-06-12 07:11:11:000
Teva Pharmaceutical Industries ( TEVA -5.5% ) continues to battle bad news. Bloomberg reports that a district court judge in Oklahoma will not approve the company's $85M settlement over its role in the opioid epidemic there because AG Mike Hunter has not shown that the proceeds will go int… read more...
Teva hits 19-year low on continued pricing pressure
via: SeekingAlpha at 2019-06-12 06:49:59:000
Teva Pharmaceutical Industries ( TEVA -4.2% ) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the continued erosion of Copaxone sales (down 56% in Q1) and its potential exposure from opioid … read more...
Teva hits 19-year low on continued pricing pressure
via: SeekingAlpha at 2019-06-12 06:49:59:000
Teva Pharmaceutical Industries ( TEVA -4.2% ) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the continued erosion of Copaxone sales (down 56% in Q1) and its potential exposure from opioid … read more...
Barclays bearish on Teva, sees 14% downside risk in premarket analyst action
via: SeekingAlpha at 2019-06-11 04:46:44:000
Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...
FDA Ad Com tomorrow on utility of higher-dose opioids
via: SeekingAlpha at 2019-06-10 13:06:51:000
The FDA's Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee will jointly mee t tomorrow and Wednesday, June 11 & 12, to seek public input on the clinical utility and safety concerns associated with higher range opioid an… read more...
FDA grants accelerated review status for Roche's Polivy for DLBCL
via: SeekingAlpha at 2019-06-10 09:02:13:000
Roche's ( OTCQX:RHHBY +0.2% ) Genentech unit announces accelerated review status in the U.S. for antibody-drug conjugate Polivy (polatuzumab vedotin-piiq), combined with chemo agent bendamustine [Teva's ( TEVA +2.2% ) Bendeka] and Rituxan (rituximab), for the treatment of adults with r… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2017-11-27 | 2017-12-12 | 2017-11-28 | 2017-11-02 | 0.085 | No Change QoQ | |||
| 2017-08-25 | 2017-09-14 | 2017-08-29 | 2017-08-03 | 0.085 | Decrease | |||
| 2017-06-01 | 2017-06-22 | 2017-06-05 | 2017-05-11 | 0.34 | No Change QoQ | |||
| 2017-02-28 | 2017-03-20 | 2017-03-02 | 2017-02-13 | 0.34 | No Change QoQ | |||
| 2016-12-01 | 2016-12-20 | 2016-12-05 | 2016-11-15 | 0.34 | No Change QoQ | |||
| 2016-08-18 | 2016-09-08 | 2016-08-22 | 2016-08-04 | 0.34 | No Change QoQ | |||
| 2016-05-20 | 2016-06-07 | 2016-05-24 | 2016-05-09 | 0.34 | No Change QoQ | |||
| 2016-02-25 | 2016-03-14 | 2016-02-29 | 2016-02-11 | 0.34 | No Change QoQ | |||
| 2015-11-13 | 2015-12-03 | 2015-11-17 | 2015-10-29 | 0.34 | No Change QoQ | |||
| 2015-08-18 | 2015-09-03 | 2015-08-20 | 2015-07-30 | 0.34 | No Change QoQ | |||
| 2015-05-15 | 2015-06-04 | 2015-05-19 | 2015-04-30 | 0.34 | No Change QoQ | |||
| 2015-02-17 | 2015-03-03 | 2015-02-19 | 2015-02-05 | 1.33 | Increase | |||
| 2014-11-13 | 2014-12-02 | 2014-11-17 | 2014-10-30 | 1.21 | No Change QoQ | |||
| 2017-11-27 | 2017-12-12 | 2017-11-28 | 0.085 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|